
117.06 Delayed Data As of Jan 22 | ![]() Today’s Change | 72.14 Today|||52-Week Range 136.26 | +22.13% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $10.9B |
Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego California 92130 |
Kevin Charles Gorman | Chief Executive Officer & Director |
Matthew C. Abernethy | Chief Financial Officer |
Dimitri E. Grigoriadis | Chief Research Officer |
Bill Wilson | Vice President-Information Technology & Operations |
Eiry W. Roberts | Chief Medical Officer |